Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last SFr.99.98 CHF
Change Today +1.45 / 1.47%
Volume 300.0K
NOVNEE On Other Exchanges
New York
SIX Swiss Ex
SIX Swiss Ex
As of 11:13 AM 07/29/15 All times are local (Market data is delayed by at least 15 minutes).

Transactions by NOVARTIS AG-2ND LINE (NOVNEE) in the last 6 months

Announced 03/30/15
25.00M for Aduro BioTech, Inc.
Private Placement

Aduro BioTech, Inc. announced that it has received $25 million in a round of funding from new investor Novartis AG on March 30, 2015. As a result of the transaction, the investor has acquired 2.7% stake in the company. The investor has also committed to invest another $25 million at a future date,

NOVNEE's price was unchanged after the transaction was announced on 03/30/15.
Investor / Buyer
Novartis AG
Announced 03/13/15
Valneva SE

GlaxoSmithKline plc (LSE:GSK) acquired 4.96% stake in Valneva SE (ENXTPA:VLA) from Novartis AG (SWX:NOVN) on March 3, 2015.

NOVNEE's price was unchanged after the transaction was announced on 03/13/15.
Investor / Buyer
GlaxoSmithKline plc
Creditor / Lender
Novartis AG

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NOVNEE:SW SFr.99.98 CHF +1.45

NOVNEE Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Allergan plc $337.99 USD -1.51
Amgen Inc $171.47 USD -1.27
Gilead Sciences Inc $115.71 USD +2.64
Johnson & Johnson $99.73 USD +0.71
Nestle SA SFr.72.90 CHF +1.00
View Industry Companies

Industry Analysis


Industry Average

Valuation NOVNEE Industry Range
Price/Earnings 26.0x
Price/Sales 4.8x
Price/Book 3.1x
Price/Cash Flow 14.1x
TEV/Sales 4.8x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NOVARTIS AG-2ND LINE, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at